These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27145090)

  • 21. Amyotrophic lateral sclerosis: early predictors of prolonged survival.
    Czaplinski A; Yen AA; Appel SH
    J Neurol; 2006 Nov; 253(11):1428-36. PubMed ID: 16773270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of amyotrophic lateral sclerosis and effect of riluzole on disease course.
    Cetin H; Rath J; Füzi J; Reichardt B; Fülöp G; Koppi S; Erdler M; Ransmayr G; Weber J; Neumann K; Hagmann M; Löscher WN; Auff E; Zimprich F
    Neuroepidemiology; 2015; 44(1):6-15. PubMed ID: 25571962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Very late-onset amyotrophic lateral sclerosis in a Portuguese cohort.
    Santos MO; Gromicho M; Pinto S; de Carvalho M
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):619-622. PubMed ID: 30265147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second-generation Irish genome-wide association study for amyotrophic lateral sclerosis.
    McLaughlin RL; Kenna KP; Vajda A; Bede P; Elamin M; Cronin S; Donaghy CG; Bradley DG; Hardiman O
    Neurobiol Aging; 2015 Feb; 36(2):1221.e7-13. PubMed ID: 25442119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey.
    Clavelou P; Blanquet M; Peyrol F; Ouchchane L; Gerbaud L
    J Neurol Sci; 2013 Aug; 331(1-2):126-31. PubMed ID: 23809193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.
    Mehta P; Antao V; Kaye W; Sanchez M; Williamson D; Bryan L; Muravov O; Horton K; ;
    MMWR Suppl; 2014 Jul; 63(7):1-14. PubMed ID: 25054277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demographic characteristics and prognosis in a Flemish amyotrophic lateral sclerosis population.
    Thijs V; Peeters E; Theys P; Matthijs G; Robberecht W
    Acta Neurol Belg; 2000 Jun; 100(2):84-90. PubMed ID: 10934559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction.
    Haverkamp LJ; Appel V; Appel SH
    Brain; 1995 Jun; 118 ( Pt 3)():707-19. PubMed ID: 7600088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors and survival of ALS patients from Belgrade, Serbia.
    Stevic Z; Kostic-Dedic S; Peric S; Dedic V; Basta I; Rakocevic-Stojanovic V; Lavrnic D
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):508-514. PubMed ID: 27315438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rate of disease progression: a prognostic biomarker in ALS.
    Labra J; Menon P; Byth K; Morrison S; Vucic S
    J Neurol Neurosurg Psychiatry; 2016 Jun; 87(6):628-32. PubMed ID: 26152368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival and epidemiology of amyotrophic lateral sclerosis (ALS) cases in the Chicago and Detroit metropolitan cohort: incident cases 2009-2011 and survival through 2018.
    Punjani R; Larson TC; Wagner L; Davis B; Horton DK; Kaye W
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):203-211. PubMed ID: 36200180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of clinical factors, riluzole and therapeutic interventions on ALS survival: a population based study in Modena, Italy.
    Georgoulopoulou E; Fini N; Vinceti M; Monelli M; Vacondio P; Bianconi G; Sola P; Nichelli P; Mandrioli J
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):338-45. PubMed ID: 23373475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irish Amyotrophic Lateral Sclerosis Incidence: Age, Period, and Cohort Effects Using a Partial Least Squares Regression Model.
    McFarlane R; Heverin M; Walsh C; Hardiman O
    Neurology; 2024 Jun; 102(11):e209391. PubMed ID: 38728654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between co-medications and survival in ALS-a cohort study from Austria.
    Cetin H; Klickovic U; Rath J; Zulehner G; Füzi J; Reichardt B; Hagmann M; Wanschitz J; Löscher WN; Auff E; Zimprich F
    J Neurol; 2015 Jul; 262(7):1698-705. PubMed ID: 25957641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland.
    Rooney J; Byrne S; Heverin M; Tobin K; Dick A; Donaghy C; Hardiman O
    J Neurol Neurosurg Psychiatry; 2015 May; 86(5):496-501. PubMed ID: 25550416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stratification of ALS patients' survival: a population-based study.
    Marin B; Couratier P; Arcuti S; Copetti M; Fontana A; Nicol M; Raymondeau M; Logroscino G; Preux PM
    J Neurol; 2016 Jan; 263(1):100-11. PubMed ID: 26518423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study.
    Murphy M; Quinn S; Young J; Parkin P; Taylor B
    Neurology; 2008 Dec; 71(23):1889-95. PubMed ID: 19047561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of ALS in Korea using nationwide big data.
    Jun KY; Park J; Oh KW; Kim EM; Bae JS; Kim I; Kim SH
    J Neurol Neurosurg Psychiatry; 2019 Apr; 90(4):395-403. PubMed ID: 30409890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
    Turner MR; Bakker M; Sham P; Shaw CE; Leigh PN; Al-Chalabi A
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar; 3(1):15-21. PubMed ID: 12061944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005.
    Kihira T; Yoshida S; Okamoto K; Kazimoto Y; Ookawa M; Hama K; Miwa H; Kondo T
    J Neurol Sci; 2008 May; 268(1-2):95-101. PubMed ID: 18164728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.